Biomerica, Inc.
BMRA
$3.88
$0.123.19%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.61% | 7.83% | 0.61% | 16.27% | 10.67% |
| Total Depreciation and Amortization | 9.17% | 10.23% | 9.22% | 6.55% | -36.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.33% | 38.17% | -3.79% | -54.03% | 250.49% |
| Change in Net Operating Assets | 0.39% | -2,480.00% | 115.17% | -897.37% | 89.71% |
| Cash from Operations | 20.00% | 4.30% | 9.76% | 2.06% | 39.77% |
| Capital Expenditure | 11.11% | 27.27% | 41.18% | 20.31% | 69.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.56% | 20.97% | 60.71% | -357.14% | -19,600.00% |
| Cash from Investing | 41.90% | 23.16% | 51.40% | -47.44% | -19.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.02% | -95.12% | -- | -- | 275.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 80.98% | 85.76% | 87.69% | 88.51% | -1,120.97% |
| Cash from Financing | -72.31% | -95.95% | -101.06% | -100.86% | 253.76% |
| Foreign Exchange rate Adjustments | -222.22% | 11.11% | 76.47% | 122.22% | 117.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -214.54% | -330.38% | -370.15% | -245.95% | 128.91% |